
Altimmune ALT
€ 1.21
-5.67%
Altimmune EV | ALT
EV Jährlich Altimmune
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 329 M | 442 M | 355 M | 503 M | 163 M | 375 M | 22.8 M | -18 M | 29 M | 51.3 M | -9.05 M | -10.9 M | -234 K | -1.27 M | -4.1 M | 3.2 M | -2.67 M |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 503 M | -18 M | 131 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Repare Therapeutics
RPTX
|
-9.3 M | - | - | $ 112 M | ||
|
Sesen Bio
SESN
|
66.6 M | - | 7.29 % | $ 127 M | ||
|
Windtree Therapeutics
WINT
|
81.3 M | - | - | $ 26.8 M | ||
|
Trean Insurance Group
TIG
|
1.47 B | - | - | $ 316 M | ||
|
SQZ Biotechnologies Company
SQZ
|
-3.96 M | - | 57.95 % | $ 12.8 M | ||
|
MEI Pharma
MEIP
|
-4.64 M | - | 10.43 % | $ 20.5 M | ||
|
Palatin Technologies
PTN
|
35.7 M | - | - | $ 13 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
Lyra Therapeutics
LYRA
|
30.9 M | - | - | $ 24.9 M | ||
|
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M | ||
|
Applied Therapeutics
APLT
|
-49.7 M | - | - | $ 8.42 M | ||
|
ESSA Pharma
EPIX
|
-26.7 M | - | - | $ 8.86 M | ||
|
Generation Bio Co.
GBIO
|
68.7 M | - | - | $ 344 M | ||
|
Clearside Biomedical
CLSD
|
44 M | - | - | $ 25.3 M | ||
|
Merus N.V.
MRUS
|
2.82 B | - | - | $ 5.78 B | ||
|
RAPT Therapeutics
RAPT
|
-72 M | - | - | $ 2.36 B | ||
|
Annexon
ANNX
|
673 M | $ 3.11 | -8.94 % | $ 482 M | ||
|
Acasti Pharma
ACST
|
-14.2 M | - | 4.01 % | $ 150 M | ||
|
Aptose Biosciences
APTO
|
36.2 M | - | -45.71 % | $ 1.2 M | ||
|
Galapagos NV
GLPG
|
1.99 B | - | - | $ 1.83 B | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-3.1 M | - | -4.36 % | $ 27 M | ||
|
Avenue Therapeutics
ATXI
|
-1.76 M | - | -52.27 % | $ 4.45 M | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
-795 K | $ 4.63 | 21.05 % | $ 20 M | ||
|
Achieve Life Sciences
ACHV
|
126 M | $ 6.78 | 0.89 % | $ 296 M | ||
|
Leap Therapeutics
LPTX
|
-4.36 M | - | 368.57 % | $ 41.9 M | ||
|
Lumos Pharma
LUMO
|
2.85 M | - | - | $ 35.3 M | ||
|
Gamida Cell Ltd.
GMDA
|
283 M | - | -18.25 % | $ 5.04 M | ||
|
Axcella Health
AXLA
|
22.6 M | - | -16.42 % | $ 249 M | ||
|
Metacrine
MTCR
|
-35.4 M | - | - | $ 24.2 M | ||
|
Zealand Pharma A/S
ZEAL
|
866 M | - | 0.52 % | $ 821 M | ||
|
Myovant Sciences Ltd.
MYOV
|
587 M | - | -0.04 % | $ 2.62 B | ||
|
Bellerophon Therapeutics
BLPH
|
77.1 M | - | -74.18 % | $ 955 K | ||
|
Idera Pharmaceuticals
IDRA
|
51.5 M | - | -23.04 % | $ 26.6 M | ||
|
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | ||
|
Verona Pharma plc
VRNA
|
43.8 B | - | - | $ 69.7 B | ||
|
Atreca
BCEL
|
94.8 M | - | -11.76 % | $ 5.79 M | ||
|
Guardion Health Sciences
GHSI
|
-2.59 M | - | -0.31 % | $ 3.64 M | ||
|
Opiant Pharmaceuticals
OPNT
|
102 M | - | - | $ 109 M | ||
|
Akouos
AKUS
|
107 M | - | 0.23 % | $ 488 M | ||
|
ImmunoGen
IMGN
|
935 M | - | - | $ 7.92 B | ||
|
Vascular Biogenics Ltd.
VBLT
|
-6.87 M | - | -8.77 % | $ 12.4 M | ||
|
Cidara Therapeutics
CDTX
|
9.99 M | - | - | $ 1.41 B | ||
|
Iterum Therapeutics
ITRM
|
52.5 M | - | - | $ 591 K | ||
|
Virpax Pharmaceuticals
VRPX
|
1.81 M | - | -45.12 % | $ 2.85 M | ||
|
Navidea Biopharmaceuticals
NAVB
|
19.5 M | - | -2.99 % | $ 2.47 M | ||
|
Stealth BioTherapeutics Corp
MITO
|
499 M | - | - | $ 23.9 M | ||
|
OncoSec Medical Incorporated
ONCS
|
26.7 M | - | 31.87 % | $ 1.61 M |